Brazil appears to have jumped the gun by officially announcing the dispatch of a plane to transport two million doses of the Covid-19 vaccine from India, and New Delhi made it clear on Thursday that decisions on supplies to foreign countries will take longer. A statement issued by Brazil’s Foreign …
Read More »Serum Institute of India: Covishield submission for vaccine campaign is a historic moment | India News
PUNE: Serum Institute of India (SII) CEO Adar Poonawalla on Tuesday he described the shipment of Covishield vaccines for the January 16 national inoculation drive as a “proud and historic” moment. Early Tuesday morning, the first shipment of vaccines left the SII facilities in Pune for transport to various parts …
Read More »3 more cases of UK strain in Chennai; WHO ‘disappointed’ when China blocks entry to Covid-19 experts
“I have been in contact with senior Chinese officials and once again I have made it clear that the mission is a priority for the WHO,” he said of the trip that he said took place with Beijing. The mission was to be led by Peter Ben Embarek, the WHO’s …
Read More »After vaccination, those reinfected may have milder symptoms: Guleria | India News
NEW DELHI: Even when the chances of re-infection with Covid-19 are low, vaccination against Covid-19 is likely to protect people from severe symptoms if a new infection occurs after the immunity of the vaccine expires, says AIIMS director Dr. Randeep Guleria. Dr. Guleria said that long-term studies will be needed …
Read More »Share Market Today LIVE | Sensex, Nifty, BSE, NSE, Stock Prices, Stock Market News Updates Jan 4
India’s drug regulator has approved the Oxford Covid-19 Covishield vaccine, manufactured by the Serum Institute of India (SII), and the indigenously developed Bharat Biotech Covaxin. Stock Market News Today | Sensex, Nifty, stock prices LIVE: National stock benchmarks were trading at a profit on Monday. S&P BSE Sensex rose more …
Read More »Coronavirus | Ready to Implement COVID-19 Vaccine in India: Serum Institute of India
The company has already stockpiled about 50 million doses of the vaccine. The Serum Institute of India (SII) said on Sunday that it is ready to launch the Covishield vaccine in the country in the coming weeks after receiving approval from India’s drug regulator. The Pune-based vaccine specialist has started …
Read More »Covid-19 Vaccines Are 110% Safe, Impotence Rumors Make No Sense: DCGI | India News
NEW DELHI: As India prepares for the world’s largest vaccination program, India’s Controller General of Drugs (DCGI) on Sunday quelled rumors surrounding Covid-19 vaccines regarding impotence, dismissing those speculations as “complete nonsense”. “We will never approve anything if there is the slightest concern for safety. Vaccines are 110% safe. Some …
Read More »‘It was finally worth it’: Adar Poonawalla thanks Prime Minister Modi, DCGI after Covishield gets final approval
For the executive director of the Serum Institute of India, Adar Poonawalla, the moment of happy new year came on January 3 after the General Controller of Drugs of India on Sunday gave the final go-ahead to Covishield, the vaccine developed by the Oxford University and leading pharmaceutical Astrazeneca and …
Read More »Medic regulator chief press conference today, approval of Covid-19 vaccines is likely
The head of India’s drug regulator will deliver a press conference on Sunday, a day after his experts recommended allowing the emergency use in the country of the Oxford-AstraZeneca and Bharat Biotech vaccines against the coronavirus disease ( Covid-19), according to reports. . The Comptroller General of Drugs of India …
Read More »Electoral process-based vaccination campaign, says Harsh Vardhan; Regulator likely to specify dosage details today
The other vaccine, known as COVAXIN, has been developed locally by Bharat Biotech and the government-run Indian Council for Medical Research. Reuters, citing sources, reported on Friday that the injection could be approved, although little is known about the results of its clinical trials. “Granting permission for restricted use in …
Read More »